SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Operating cash flow 2021–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.0MFY2025 · since FY2021: -$7.4M → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | +4.8% |
| FY2024 | -$6.3M | +32.5% |
| FY2023 | -$9.4M | -29.1% |
| FY2022 | -$7.3M | +2.2% |
| FY2021 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →